The blinded, randomized clinical trial compares outcomes for spinal fusions between the composite silicon nitride fusion device to PEEK spacers filled with bone autograft.
Amedica’s CASCADE includes a central core of cancellous structured ceramic.
Netherlands-based Mark P. Arts, MD, will present the findings and Amedica Chairman and CEO Sonny Bal, MD, will discuss the study’s potential impact on Amedica’s business.
More articles on orthopedic devices:
Stryker, Medtronic, Zimmer & more—16 key notes
Spine device stock report: 5 key companies
LDR director sells 50k shares—5 key updates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
